Author: Klopper, Marisa
Similar Items: Undetected isoniazid mono resistance in rural Eastern Cape Province - A risk for the emergence of multidrug-resistant TB
- The prevalence of isoniazid and rifampicin resistance of Mycobacterium tuberculosis
- Investigating permeation of anti-mycobacterial agents in Mycobacterium tuberculosis and M. tuberculosis-infected macrophages in vitro as a model for early stage tuberculosis drug discovery
- Does the inclusion of the cost and burden of adverse drug reactions associated with drug-resistant TB treatment affect the incremental cost-effectiveness of new treatment regimens? A case study from the introduction of bedaquiline in South Africa National TB Programme
- Outcomes of patients undergoing lung resection for drug-resistant TB and the prognostic significance of pre-operative positron emission tomography/computed tomography (PET/CT) in predicting treatment failure
- Risk factors associated with isoniazid resistance in tuberculosis
- Population pharmacokinetic modelling to optimise treatment for children with Rifampicin-resistant TB and HIV